FBRX Stock Price Chart
FBRX Earnings
Forte Biosciences Inc
$43.92
19.67%
$7.21
At close: Jul 10, 16:00:00 GMT-4
$44.22
0.68%
$0.29
Post-market: Jul 10, 19:49:23 GMT-4
Back
Forte Biosciences Inc (FBRX) Earnings
Key Stats
Prev.Close
$36.7
Open
$37.94
Day's Range
$37.5 - $45.33
52 week range
$9.1 - $44.22
Volume
3.1M
Avg.Volume
319.3K
Dividend yield
--
EPS (TTM)
-4.58
Market Cap
$905.6M
What is FBRX?
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 14 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.
